Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

548.05
+7.791.44%
Post-market: 548.050.00000.00%19:52 EDT
Volume:1.07M
Turnover:589.66M
Market Cap:139.05B
PE:31.90
High:555.32
Open:545.10
Low:540.70
Close:540.26
52wk High:555.32
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.86
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.87
PE(LYR):35.77

Loading ...

Oct 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Correspondence

Form CORRESP - Correspondence
May 05, 2025

Major Issues Report

Form 8-K - Current report
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities